US Stock MarketDetailed Quotes

Edgewise Therapeutics (EWTX)

Watchlist
  • 29.780
  • +0.540+1.85%
Close Jan 22 16:00 ET
  • 29.780
  • 0.0000.00%
Pre 08:18 ET
3.15BMarket Cap-18.97P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Edgewise Therapeutics (EWTX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
15.89%46.86M
11.82%42.61M
32.24%45.96M
38.89%158.83M
34.49%45.54M
37.28%40.43M
50.39%38.11M
35.20%34.75M
59.59%114.36M
53.37%33.86M
Selling and administrative expenses
14.23%9.38M
21.88%9.05M
30.36%9.2M
35.88%31.87M
48.43%9.17M
44.90%8.21M
28.49%7.43M
21.12%7.06M
33.05%23.45M
13.01%6.18M
-General and administrative expense
14.23%9.38M
21.88%9.05M
30.36%9.2M
35.88%31.87M
48.43%9.17M
44.90%8.21M
28.49%7.43M
21.12%7.06M
33.05%23.45M
13.01%6.18M
Research and development costs
16.32%37.48M
9.38%33.56M
32.73%36.76M
39.67%126.97M
31.38%36.37M
35.47%32.22M
56.86%30.68M
39.33%27.69M
68.24%90.91M
66.65%27.68M
Operating profit
-15.89%-46.86M
-11.82%-42.61M
-32.24%-45.96M
-38.89%-158.83M
-34.49%-45.54M
-37.28%-40.43M
-50.39%-38.11M
-35.20%-34.75M
-59.59%-114.36M
-53.37%-33.86M
Net non-operating interest income expense
-1.76%6.19M
-1.74%6.5M
-17.13%5.16M
76.26%25.02M
58.05%5.88M
68.57%6.3M
70.80%6.61M
117.31%6.23M
253.26%14.19M
39.60%3.72M
Non-operating interest income
-1.76%6.19M
-1.74%6.5M
-17.13%5.16M
76.26%25.02M
58.05%5.88M
68.57%6.3M
70.80%6.61M
117.31%6.23M
253.26%14.19M
39.60%3.72M
Other net income (expense)
Income before tax
-19.15%-40.67M
-14.66%-36.12M
-43.03%-40.8M
-33.60%-133.81M
-31.58%-39.66M
-32.73%-34.13M
-46.71%-31.5M
-24.90%-28.53M
-48.08%-100.16M
-55.26%-30.14M
Income tax
Net income
-19.15%-40.67M
-14.66%-36.12M
-43.03%-40.8M
-33.60%-133.81M
-31.58%-39.66M
-32.73%-34.13M
-46.71%-31.5M
-24.90%-28.53M
-48.08%-100.16M
-55.26%-30.14M
Net income continuous Operations
-19.15%-40.67M
-14.66%-36.12M
-43.03%-40.8M
-33.60%-133.81M
-31.58%-39.66M
-32.73%-34.13M
-46.71%-31.5M
-24.90%-28.53M
-48.08%-100.16M
-55.26%-30.14M
Minority interest income
Net income attributable to the parent company
-19.15%-40.67M
-14.66%-36.12M
-43.03%-40.8M
-33.60%-133.81M
-31.58%-39.66M
-32.73%-34.13M
-46.71%-31.5M
-24.90%-28.53M
-48.08%-100.16M
-55.26%-30.14M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-19.15%-40.67M
-14.66%-36.12M
-43.03%-40.8M
-33.60%-133.81M
-31.58%-39.66M
-32.73%-34.13M
-46.71%-31.5M
-24.90%-28.53M
-48.08%-100.16M
-55.26%-30.14M
Basic earnings per share
-8.33%-0.39
0.00%-0.34
-30.30%-0.43
7.64%-1.45
10.64%-0.42
12.20%-0.36
0.00%-0.34
8.33%-0.33
-24.60%-1.57
-56.67%-0.47
Diluted earnings per share
-8.33%-0.39
0.00%-0.34
-30.30%-0.43
7.64%-1.45
10.64%-0.42
12.20%-0.36
0.00%-0.34
8.33%-0.33
-24.60%-1.57
-56.67%-0.47
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 15.89%46.86M11.82%42.61M32.24%45.96M38.89%158.83M34.49%45.54M37.28%40.43M50.39%38.11M35.20%34.75M59.59%114.36M53.37%33.86M
Selling and administrative expenses 14.23%9.38M21.88%9.05M30.36%9.2M35.88%31.87M48.43%9.17M44.90%8.21M28.49%7.43M21.12%7.06M33.05%23.45M13.01%6.18M
-General and administrative expense 14.23%9.38M21.88%9.05M30.36%9.2M35.88%31.87M48.43%9.17M44.90%8.21M28.49%7.43M21.12%7.06M33.05%23.45M13.01%6.18M
Research and development costs 16.32%37.48M9.38%33.56M32.73%36.76M39.67%126.97M31.38%36.37M35.47%32.22M56.86%30.68M39.33%27.69M68.24%90.91M66.65%27.68M
Operating profit -15.89%-46.86M-11.82%-42.61M-32.24%-45.96M-38.89%-158.83M-34.49%-45.54M-37.28%-40.43M-50.39%-38.11M-35.20%-34.75M-59.59%-114.36M-53.37%-33.86M
Net non-operating interest income expense -1.76%6.19M-1.74%6.5M-17.13%5.16M76.26%25.02M58.05%5.88M68.57%6.3M70.80%6.61M117.31%6.23M253.26%14.19M39.60%3.72M
Non-operating interest income -1.76%6.19M-1.74%6.5M-17.13%5.16M76.26%25.02M58.05%5.88M68.57%6.3M70.80%6.61M117.31%6.23M253.26%14.19M39.60%3.72M
Other net income (expense)
Income before tax -19.15%-40.67M-14.66%-36.12M-43.03%-40.8M-33.60%-133.81M-31.58%-39.66M-32.73%-34.13M-46.71%-31.5M-24.90%-28.53M-48.08%-100.16M-55.26%-30.14M
Income tax
Net income -19.15%-40.67M-14.66%-36.12M-43.03%-40.8M-33.60%-133.81M-31.58%-39.66M-32.73%-34.13M-46.71%-31.5M-24.90%-28.53M-48.08%-100.16M-55.26%-30.14M
Net income continuous Operations -19.15%-40.67M-14.66%-36.12M-43.03%-40.8M-33.60%-133.81M-31.58%-39.66M-32.73%-34.13M-46.71%-31.5M-24.90%-28.53M-48.08%-100.16M-55.26%-30.14M
Minority interest income
Net income attributable to the parent company -19.15%-40.67M-14.66%-36.12M-43.03%-40.8M-33.60%-133.81M-31.58%-39.66M-32.73%-34.13M-46.71%-31.5M-24.90%-28.53M-48.08%-100.16M-55.26%-30.14M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -19.15%-40.67M-14.66%-36.12M-43.03%-40.8M-33.60%-133.81M-31.58%-39.66M-32.73%-34.13M-46.71%-31.5M-24.90%-28.53M-48.08%-100.16M-55.26%-30.14M
Basic earnings per share -8.33%-0.390.00%-0.34-30.30%-0.437.64%-1.4510.64%-0.4212.20%-0.360.00%-0.348.33%-0.33-24.60%-1.57-56.67%-0.47
Diluted earnings per share -8.33%-0.390.00%-0.34-30.30%-0.437.64%-1.4510.64%-0.4212.20%-0.360.00%-0.348.33%-0.33-24.60%-1.57-56.67%-0.47
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.00%
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +7.44%
4
KE Holdings
BEKE
+5.08%
5
NIO Inc
NIO
+4.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -